BUSINESS● LOWSep 22 · Sep 22, 2026, 4:44 AM
Nvidia-backed AI drugmaker Iambic Therapeutics seeks U.S. listing
Seeking Alpha Tech · north america
Iambic Therapeutics, an AI drugmaker supported by Nvidia, is reportedly seeking a listing in the United States. This move highlights the growing investment and public interest in AI-driven biotechnology companies.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS31m agoMicrosoft is the only hyperscaler not forecast to dip into negative FCF in the next yearSeeking Alpha TechBUSINESS34m agoRegions expects Q4 2026 net interest income up 1%-2% as deposit platform conversion targets mid-2027Seeking Alpha Tech